Bikram Yoga and Asthma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2006 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Information provided by:
Hadassah Medical Organization Identifier:
First received: December 10, 2006
Last updated: December 11, 2006
Last verified: December 2006
Cold and dry air induce exercise induced asthma. Yoga training may improve lung function tests. Bikram Yoga (heat 39 degree Celsius and humidity 60%)training may improve both lung function tests and bronchial hyperreactivity (to exercise and adenosine 5'monophosphate).

Condition Intervention
Behavioral: Bikram Yoga

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: The Influence of Bikram Yoga (39 Degree Celsius Heat and 60% Humidity) on Basic Lung Function Tests,Bronchial Challenges and Pulmonary-Heart Endurance in Young Asthmatic Adults.

Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • prevent exercise induced asthma and improve lung function tests

Estimated Enrollment: 30
Study Start Date: June 2007
Detailed Description:
15 young adults with exercise induced asthma and 10 healthy young adults will participate in 2 months taining of Bikram Yoga in Tel Aviv. They will perform sessions of 90 minutes training at least 5 times a week. Lung function tests, bronchial challenges (exercise and AMP) and progressive exercise test will be performed before and after the 2 month training at Hadassah University Hospital in Jerusalem in the asthmatic patients. Healthy adults will perform only lung function tsts and progressive exercise before and after training.

Ages Eligible for Study:   18 Years to 30 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • controlled asthma
  • age 18-30 years

Exclusion Criteria:

  • heart,
  • hypertension,
  • kidney disease,
  • chronic lung disease,
  • oxygen dependence
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00410098

Contact: Avraham AVITAL, Prof, MD

Sponsors and Collaborators
Hadassah Medical Organization
Principal Investigator: Avraham AVITAL, MD, Prof Hadassah Medical Organization
  More Information Identifier: NCT00410098     History of Changes
Other Study ID Numbers: bikramasthma-HMO-CTIL 
Study First Received: December 10, 2006
Last Updated: December 11, 2006
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Hadassah Medical Organization:

Additional relevant MeSH terms:
Bronchial Diseases
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Respiratory Tract Diseases processed this record on May 26, 2016